Conviction rising: building the full AI silicon and tools stack
The biggest adds cluster tightly around one idea: the AI bottleneck is migrating from headline GPUs to capacity, memory, and tools.
- Micron (MU) is the standout: a 165.3% position increase and about $10.2B of incremental capital says they see high-bandwidth memory as the next choke point in AI systems, not an afterthought.
- Alphabet GOOGL is up 25.8% with roughly $7.4B added, even as the GOOG line is trimmed. That is a deliberate consolidation into a single share class and a statement that hyperscale AI infrastructure and first-party models still earn a premium slot.
- Lam Research (LRCX) and Applied Materials (AMAT) both more than double in share terms (up 85.8% and 108.3% respectively in shares), with a combined near-$9.7B increase. That is a straight read-through: fabs, not front-end apps, are where the incremental dollar of AI capex gets spent.
- AMD and Marvell (MRVL) see aggressive adds — AMD up 24.6%, Marvell up 714.3% in shares and about $3.6B more capital — which rounds out a bet that alternative accelerators, networking silicon, and custom silicon will carve out real profit pools alongside Nvidia.
- Taiwan Semi (TSM) and ASML are both boosted (TSM shares up 38.7%, ASML up 25.7%), tying the thesis together: if you think AI volumes sustain, you must own the bottleneck nodes and the lithography monopoly.
Around the edges, they also add to linchpin analog/connectivity names like Amphenol and to utility Southern, suggesting they see AI as a power and bandwidth story as much as a chip story.
Conviction
The big buys
The biggest dollar adds this quarter — where conviction is rising.
| Position | Change | Portfolio weight | Value |
|---|---|---|---|
| MUMICRON TECHNOLOGY INC | Added 165.3%+$10.19B | 1.6% | $16.35B |
| GOOGLALPHABET INC | Added 25.8%+$7.44B | 3.6% | $36.21B |
| LRCXLAM RESEARCH CORP | Added 85.8%+$4.92B | 1.1% | $10.66B |
| AMATAPPLIED MATLS INC | Added 108.3%+$4.75B | 0.9% | $9.13B |
| AMDADVANCED MICRO DEVICES INC | Added 24.6%+$4.12B | 2.1% | $20.88B |
| MRVLMARVELL TECHNOLOGY INC | Added 714.3%+$3.61B | 0.4% | $4.12B |
| JNJJOHNSON & JOHNSON | Added 39.4%+$1.65B | 0.6% | $5.84B |
| TSMTAIWAN SEMICONDUCTOR MANUFAC | Added 38.7%+$1.51B | 0.5% | $5.41B |
Dollar changes estimated at current prices (shares added × current price); top-50 current positions only.
What they’re selling to pay for it: cashing in the crowd favorites
To fund that second-wave AI build-out, Price T Rowe is taking real money off the table in the most obvious winners of the last cycle.
- Apple and Microsoft are both meaningfully cut (Apple shares down 20.3%, Microsoft down 25.6%), removing roughly $11.8B and $11.2B of exposure at gains north of 200%–400% versus their average costs. These aren’t thesis breaks; they’re valuation and concentration releases.
- Amazon and Meta are trimmed as well (Amazon shares down 11.5%, Meta down 6.6%), indicating less appetite for ad and e-commerce cyclicality relative to more direct AI infrastructure leverage.
- Within Alphabet, they rotate: GOOG is reduced by 12.7% while GOOGL is sized up. That looks like a governance and liquidity preference rather than a change in view on the underlying business.
- On the networking and bandwidth side, Arista (ANET) is cut by 20.8% and Cisco modestly trimmed, just as Marvell and equipment names are boosted. They’re effectively saying the best risk-reward in AI networking now sits in silicon and wafer tools, not in box vendors.
- Consumer and financials are quiet funding sources: Netflix, Booking, Procter & Gamble, Charles Schwab, Bank of America, and Visa all see net selling, marking them as tradable cash reservoirs rather than engines of future excess return in this framework.
Sector drift: even more tech, but with a new kind of cyclical ballast
At the sector level, the wheel barely turns — but the spokes are different. Technology creeps from 61.63% to 62.55% of the book, yet inside that bucket they shift from platform-heavy FAAMG exposure toward semiconductors, foundries, and equipment.
Consumer Discretionary ticks down from 9.94% to 9.0% as Amazon, Netflix, Booking, and Carvana bleed capital, even while Home Depot is quietly added. That looks like a move away from online ad and demand-volatility toward more tangible-cycle plays tied to housing and construction.
Health care edges up from 7.92% to 8.43%, led by sizable increases in Johnson & Johnson, UnitedHealth, Gilead, Stryker, and AbbVie. This is classic ballast: cashing in hyper-growth tech gains and upgrading the defensive spine in large-cap pharma, managed care, and medtech.
Finance and Real Estate both slip a touch (Finance from 5.01% to 4.81%, Real Estate from 4.91% to 4.56%) as banks, brokers, and card networks get trimmed while Welltower is increased. They’re keeping exposure to financial plumbing and real-asset income, but clearly not paying up for incremental cyclicality.
Industrials, Energy, Basic Materials, and Utilities all nudge higher, with adds to Caterpillar, Exxon, Linde, and Southern. That combination reads as a quiet macro overlay: if AI drives capex and power use, heavy equipment, chemicals, and electricity should not be an afterthought.
What this quarter implies about Price T Rowe’s next act
Taken together, the quarter describes an investor that believes the easy money in "AI beneficiaries" at the application layer has been made — but the hard money in fabs, memory, tools, and power is still ahead. The modest increase in overall tech weight hides a very intentional migration from glossy narratives to capital-intensive bottlenecks.
The pattern of trades suggests they expect AI demand and related capex to prove more durable than consumer or advertising cycles. They’re willing to own more Micron, Lam, Applied, TSM, and ASML precisely because those are the names that get hurt first in a downturn; in exchange, they dial down richly valued, broadly owned platforms like Apple, Microsoft, Amazon, and Visa.
Simultaneously, they’re upgrading the defensive core: more diversified pharma and managed care, plus a bit more utilities and real assets. That mix — higher operational leverage to AI plus sturdier health care and infrastructure — looks like preparation for a world where index-level multiples might compress even as select industrial ecosystems still compound.
If you want to understand where this book goes next, watch two clusters: the semiconductor equipment and memory complex, and the big diversified health care names they have been building. If those keep growing at the expense of consumer internet and financials, Price T Rowe will have finished turning a broad "quality growth" book into a highly opinionated bet on the physical backbone of the AI economy.
Frequently asked questions
What did Price T Rowe Associates INC Md buy in 2026-Q2?+
In 2026-Q2, Price T Rowe Associates INC Md added heavily to AI-related semiconductors and tools, including large increases in Micron, Lam Research, Applied Materials, AMD, Marvell, Taiwan Semiconductor, ASML, and the GOOGL share class of Alphabet. They also added to several health care names such as Johnson & Johnson, UnitedHealth, Gilead, Stryker, and AbbVie.
What did Price T Rowe Associates INC Md sell in 2026-Q2?+
They funded those buys by trimming mega-cap platforms and select consumer and financial holdings. Notable reductions included Apple, Microsoft, Amazon, the GOOG share class of Alphabet, Meta, Arista Networks, Visa, Netflix, Booking Holdings, Charles Schwab, and Bank of America.
What is Price T Rowe Associates INC Md's biggest holding as of 2026-Q2?+
Nvidia is the largest disclosed position at 7.41% of the reported equity portfolio. The stake was essentially maintained, indicating continued high conviction in Nvidia as a core AI beneficiary even as they shift incremental capital to other parts of the semiconductor stack.
How is Price T Rowe Associates INC Md positioned toward the technology sector?+
Technology is the dominant exposure at 62.55% of the reported book, up from 61.63% the prior quarter. Within tech, the firm is rotating from consumer-facing platforms toward semiconductors, foundries, and chip equipment such as Micron, AMD, Lam Research, Applied Materials, Marvell, Taiwan Semi, and ASML.
Did Price T Rowe Associates INC Md change its exposure to health care in 2026-Q2?+
Yes. Health care weight increased from 7.92% to 8.43%, with significant adds to Johnson & Johnson, UnitedHealth, Gilead, Stryker, and AbbVie. That pattern suggests the fund is reinforcing health care as a defensive and cash-generating complement to its higher-beta tech bets.
How did Price T Rowe Associates INC Md's portfolio reflect its AI thesis this quarter?+
The portfolio shifts show a move beyond headline AI winners toward the underlying infrastructure. By maintaining Nvidia while significantly increasing positions in Micron, Lam Research, Applied Materials, AMD, Marvell, Taiwan Semi, and ASML, the fund is expressing a view that the most attractive incremental returns now lie in memory, foundry capacity, and chipmaking equipment rather than just in front-end AI platforms.